CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Sales	$ 10,412,491	$ 683,730
Sales related party	0	0
Total gross sales	10,412,491	683,730
Allowances	(264,255)	(218,042)
Net sales	10,148,236	465,687
Net sales related party	0	0
Total net sales	10,148,236	465,687
Costs of sales	3,700,537	165,492
Gross profit	6,447,699	300,196
Operating expenses	12,560,297	1,391,812
Income (loss) from operations	(6,112,598)	(1,091,617)
Realized and unrealized gain (loss) on marketable securities	(62,010)	0
Decrease of contingent liability	16,898,006	0
Interest income	7,267	37,686
Income (loss) before provision for income taxes	10,730,665	(1,053,931)
Benefit for income taxes	2,240,300	133,000
Net income (loss) from continuing operations	12,970,965	(920,931)
Net loss from discontinued operations, net of tax (Note 15)	(41,202)	(1,268,111)
Net income (loss)	12,929,763	(2,189,042)
Net loss attributable to non-controlling interest from discontinued operations (Note 15)	0	(79,149)
Preferred dividends	66,734	0
Net income (loss) attributable to cbdMD, Inc. common shareholders	$ 12,863,029	$ (2,109,893)
Net income (loss) per share:
Basic earnings per share	$ 0.46	$ (0.21)
Diluted earnings per share	$ 0.45	$ .00
Weighted average number of shares - basic	27,720,356	10,052,960
Weighted average number of shares - diluted	28,553,856	10,052,960